Rebecca Beausang
Regulatory Affairs Specialist, Scilife
Rebecca has over seven years of experience in medical device and other regulated industries. Alongside her expertise in FDA submissions, EU MDR compliance, and ISO 13485 QMS implementation, Rebecca is skilled in creating clear and impactful regulatory content. From technical documentation to compliance blogs, she excels in translating complex topics into engaging, actionable insights. Her passion lies in using compliance as a strategic tool to drive innovation and trust in regulated markets.
If you have spent any time on a manufacturing floor, you know the feeling that kicks in when you hear an inspector has just signed into the lobby. I remember my first major site audit vividly. I had spent three weeks checking every single machine mai...
Finding the best compliance tools for pharmaceutical companies is now a survival requirement for any QARA professional overseen by increasing regulatory complexity and global supply chains. In this post, we’ll explain why pharmaceutical regulatory co...
If you’re a professional in pharmaceuticals, biotech, advanced therapy medicinal products (ATMPs), or medical devices operating in the UK, you know the gravity of an inspection conducted by the Medicines and Healthcare products Regulatory Agency (MHR...
If you're in pharmaceutical development, Quality by Design (QbD) is a term you know well. It represents an advancement in how we develop and manufacture medicines, and at its heart is the ICH Q8 guideline.
If you’ve ever been through an audit in the life sciences industry, you know how important Corrective and Preventive Actions (CAPAs) are. Regulatory bodies expect you to have a strong CAPA process in place to uphold product quality and patient safety...
Subscribe to the
Scilife Blog
Life Science and Quality resources and news. All directly to your inbox!